Acute mesenteric ischaemia is a rare complication of calcium channel blocker (CCB) overdose. A previous study reported a case of mesenteric ischaemia induced by poisoning with CCBs other than diltiazem. We present a case of nonocclusive mesenteric ischaemia (NOMI) induced by diltiazem poisoning. Through this case report, we wish to emphasize that the clinicians should keep the possibility of intestinal ischaemia in mind from the early phase of calcium channel blocker poisoning. In addition, close monitoring and intense abdominal examination including the abdominal computed tomography scan should be done if CCBs poisoning patients complained of an abdominal pain. (Hong Kong j.emerg.med. 2017;24:145-147) 
Introduction
Calcium channel blockers (CCBs) are frequently prescribed as cardiovascular medications. Emergency department visits linked to CCB poisoning are not common, but CCB poisoning can be fatal. CCB toxicities are mainly associated with decreasing cardiac contractility and peripheral vasodilation. In cases of CCB overdose, bradycardia and hypotension are common abnormal finding, 1 and associated symptoms such as dizziness, lethargy, syncope, and altered mental status are observed. Other complications such as seizures, cerebral ischaemia, renal failure, and mesenteric ischaemia are also reported related to patient condition. Although mesenteric ischaemia has been reported after poisoning with other CCBs; 2,3 to our knowledge, intestinal ischaemia due to diltiazem poisoning has not been reported previously. In this study, we present a case of nonocclusive mesenteric ischaemia (NOMI) caused by diltiazem overdose.
Case
A 22-year-old woman was brought to the our emergency department 3 hour after ingesting approximately 25 tablets of 90 mg extended-release diltiazem in a suicide attempt. She had no significant medical illness in past. On admission, her vital sign were as follows: blood pressure of 55/40 mmHg, heart rate of 72 beats/min, respiratory rate of 20 breaths/ min, and body temperature of 36.5°C. She was alert, and the results of the physical examination were normal. An electrocardiogram revealed a heart rate of 78 beats/min with a junctional rhythm but there was no electrolyte imbalance such as hypokalaemia: potassium level of 3.4 mmol/L. Arterial blood gas analysis identified metabolic acidosis as follows: pH of 7.31, bicarbonate level of 15.0 mmol/L, base excess of -10.0 mmol/L, and lactate level of 3.4 mmol/L. Her blood sugar is 14.6 mmol/L. We treated the patient with multiple dose charcoal, normal saline at 200 mL/h, and 4 g of elemental calcium. The dose of dopamine was titrated to 20 µg/kg/min and that of norepinephrine was titrated to 15 µg/min. We added 1000 mL 10% dextrose with 200 units of regular insulin at 200 ml/h (0.8U/kg/h). Her blood pressure rose to 100/40 mmHg, but her diastolic pressure remained low. Five hours after admission, she complained of vague abdominal pain; a physical examination revealed lower abdominal tenderness and guarding. We performed abdominal contrast computed tomography (CT) to identify the causes of abdominal pain and observed decreased enhancement with pneumatosis intestinalis from the distal jejunum to the ileum (Figure 1 ). These findings suggested ischaemic injury of the small bowel. After surgical consultation, a segmental resection of the small intestine and anastomosis were performed. The gross findings during exploratory laparotomy included whole bowel oedema and dilation with distal ileum segment ischaemia. Histopathological evaluation revealed segmental transmural haemorrhagic necrosis with bullous change of the mucosa. After the surgery, the patient recovered, and she was discharged on hospitalisation day 10.
Discussion
NOMI is defined as mesenteric ischaemia without an arterial or venous occlusion. Any shock conditions related to hypovolaemia, low cardiac output, and sepsis predispose patients to NOMI. Drugs (e.g., digoxin, alpha agonists, and beta-blockers) or poisoning can also cause NOMI. 4 In our case, we administered activated charcoal, crystalloid, calcium gluconate, catecholamines, and hyperinsulinaemiaeuglycaemia therapy. NOMI developed even though we initiated appropriate treatment to raise the blood pressure according to the clinical recommendation. 5 The mechanism of NOMI caused by CCB poisoning is believed to be mesenteric hypoperfusion due to drug-induced cardiogenic shock and splanchnic vasoconstriction caused by the administration of high-dose catecholamine to treat hypotension. 4 In addition, reperfusion of the bowel following ischaemia worsens ischaemic injury. 6 The pathophysiology of mesenteric ischaemia in our case seemed to be consistent with the previously suggested mechanism. However, we administered relative low dose norepinephrine (15 µg/min) compared to usually administered dose to the other shock patients in intensive care unit. Some critically ill patients often require higher dose vasopressor than standard recommended dose. 7, 8 CCB poisoning patients who were refractory to standard dose of vasopressor might be receive high dose vasopressors. 9 In spite of that, Levine et al insisted that the CCB poisoning patients in their study did not appear to undergo untoward ischemic complications of high dose vasopressors. 10 It suggested that drug-induced cardiogenic shock with initial splanchnic hypo-perfusion and consecutive reperfusion injury were more contribution to NOMI occurrence than splanchnic vasoconstriction caused by vasopressor. In contrast with previous reports, NOMI in our patient occurred in an early phase, 8 hours after of CCB poisoning. Previous study demonstrated that NOMI occurred, with a median delay of 48 hours after toxicant-induced shock. 4 This finding of early onset of NOMI after CCB poisoning, may support our hypothesis of NOMI mechanism. However, further investigation are required to confirm the exact mechanism of NOMI by CCB poisoning.
Conclusion
Through this case report, we wish to emphasize that the clinicians should keep the possibility of intestinal ischaemia or infarction in mind when patients with CCB poisoning complain about abdominal pain. A close monitoring and abdominal examination should be researched in early phase after hospitalisation of CCB poisoning patients even though the patient's hypotensive state has been recovered with a treatment including low dose vasopressor.
